29–30 Apr 2026
CERN
Europe/Zurich timezone

Session

Presentations 30th am

30 Apr 2026, 08:30
500/1-001 - Main Auditorium (CERN)

500/1-001 - Main Auditorium

CERN

400
Show room on map

Conveners

Presentations 30th am

  • Mickael Denis Crouvizier (CERN)

Presentation materials

There are no materials yet.

  1. Gregory Nichols (Oak Ridge Institute for Science and Education)
    30/04/2026, 08:30
    Medical & Epidemiological

    Beryllium is a critical industrial material and a potent occupational toxicant capable of causing beryllium sensitization (BeS) and chronic beryllium disease (CBD). Persistent disease occurring even at regulated exposure levels led the U.S. Department of Energy (DOE) to adopt a surveillance‑driven prevention strategy.

    Under 10 CFR Part 850, DOE established the Chronic Beryllium Disease...

    Go to contribution page
  2. Jonathan Gulley (CERN)
    30/04/2026, 08:50
    Technical Practices

    The use of beryllium and its alloys in high-energy physics applications at CERN requires a robust and institution-specific regulatory approach due to the material’s toxicity and the stringent cleanliness constraints associated with accelerator components. This article presents the development and implementation of a dedicated internal framework formalized through Safety Guideline SG-C-0-0-6,...

    Go to contribution page
  3. Sergey Tolmachev
    30/04/2026, 09:10
    Medical & Epidemiological

    The United States Transuranium and Uranium Registries (USTUR) was established in 1968 as Plutonium Registry by the Atomic Energy Commission. Today, the USTUR and the associated National Human Radiobiological Tissue Repository (NHRTR) is funded by the U.S. Department of Energy (DOE) Office of Health Studies and Former Workers Programs (EHSS-12).

    The USTUR mission is to study biokinetics...

    Go to contribution page
  4. Ms Nancy Wilk (International Occupational Hygiene Association)
    30/04/2026, 09:30
    Medical & Epidemiological

    While the health risks associated with occupational beryllium exposures such as chronic beryllium disease can affect both men and women, there is need for additional research into women's occupational exposures to chemical agents including beryllium. Historically, across sectors, hazards, and geographies, women have been underrepresented in occupational health studies, standards and guidance....

    Go to contribution page
  5. Mr Thierry Peseux
    30/04/2026, 09:50
    Technical Practices
  6. Ms Lisa Barker (National Jewish Health)
    30/04/2026, 10:10
    Medical & Epidemiological

    Workers occupationally exposed to beryllium are at risk of developing beryllium sensitization (BeS) and chronic beryllium disease (CBD). Risk of developing disease is related to both exposure and genetics. Some workforces use the beryllium lymphocyte proliferation test (BeLPT) as part of medical surveillance. BeLPT testing identifies workers with abnormal BeLPT’s and recommends additional...

    Go to contribution page
Building timetable...